NCT00003082
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
Clinical trial condition
Myelodysplastic-Myeloproliferative Diseases
Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.
384 public trials
62 recruiting studies
Myelodysplastic-Myeloproliferative Diseases trial results
NCT00003187
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States
- University of Minnesota Medical School Minneapolis, Minnesota, United States
NCT00145613
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Anemia, +34 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT00152139
- Conditions
- Acute Lymphoblastic Leukemias, Acute Myelocytic Leukemia, Anemia, +31 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT00186823
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +35 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT00143559
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anemia, +34 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Active, Not Recruiting
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.
NCT05201066
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
- Locations
-
- Oregon Health Sciences University Portland, Oregon, United States
- Huntsman Cancer Institute Univ of Utah Salt Lake City, Utah, United States
- Novartis Investigative Site Clayton, Victoria, Australia
- Novartis Investigative Site Florianópolis, Santa Catarina, Brazil
NCT03849651
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +33 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Active, Not Recruiting
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
- University of California, Davis - Health Systems Sacramento, California, United States
- H Lee Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations
NCT04409639
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +11 more
- Locations
-
- Oregon Health and Science University Portland, Oregon, United States
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States